Table 1.
(A) Patient information. (B) Patient medical history. (C) Presenting review of systems
| A | |||
| Patient demographics | |||
| Gender | N | ||
| Female | 46 (57%) | ||
| Male | 35 (43%) | ||
| Age | |||
| Median | 52 years | ||
| Min | 21 years | ||
| Max | 87 years | ||
| Primary language | |||
| English | 63 (78%) | ||
| Spanish | 13 (16%) | ||
| Cape Verdean | 2 (2%) | ||
| Cantonese | 2 (%) | ||
| Vietnamese | 1 (1%) | ||
| Race | |||
| White | 33 (41%) | ||
| Black | 23 (28%) | ||
| Other | 16 (20%) | ||
| Asian | 8 (10%) | ||
| Unknown | 1 (1%) | ||
| N | |||
| Hispanic | |||
| Yes | 27 (33%) | ||
| COVID-19 test result | |||
| Positive | 30 (37%) | ||
| Negative | 22 (27%) | ||
| Not tested | 29 (36%) | ||
| B | |||
| All participants (n=81) | |||
| No prior medical conditions | 51 (63%) | ||
| Congestive heart failure | 0 (0%) | ||
| Chronic obstructive pulmonary disease | 3 (4%) | ||
| Coronary artery disease | 2 (3%) | ||
| Hypertension | 27 (33%) | ||
| Diabetes | 10 (12%) | ||
| Immunosuppression | 8 (10%) | ||
| Tobacco use | 14 (17%) | ||
| C | |||
| All participants (n=81) | COVID-19 positive (n=30) | COVID-19 negative or untested (n=51) | |
| Fever | 47 (58%) | 20 (67%) | 27 (53%) |
| Anosmia/dysgeusia | 6 (7%) | 4 (13%) | 2 (4%) |
| Shortness of breath | 64 (79%) | 22 (73%) | 42 (82%) |
| Cough | 58 (72%) | 24 (80%) | 34 (67%) |
| Sputum production | 5 (6%) | 1 (3%) | 4 (8%) |
| Abdominal pain | 9 (11%) | 2 (7%) | 7 (14%) |
| All participants (n=81) | COVID-19 positive (n=30) | COVID-19 negative or untested (n=51) | |
| Chest pain | 21 (26%) | 5 (17%) | 16 (31%) |
| Chills | 18 (22%) | 8 (27%) | 10 (20%) |
| Diarrhoea | 13 (16%) | 7 (23%) | 6 (12%) |
| Fatigue | 24 (30%) | 11 (37%) | 13 (26%) |
| Headache | 7 (9%) | 2 (7%) | 5 (10%) |
| Myalgias | 21 (26%) | 8 (27%) | 13 (26%) |
| Rhinorrhea | 2 (3%) | 1 (3%) | 1 (2%) |
| Sore throat | 9 (11%) | 2 (7%) | 7 (14%) |
| Vomiting | 3 (4%) | 2 (7%) | 1 (2%) |
| Persistent pain | 7 (9%) | 3 (10%) | 4 (8%) |